Trials Currently Recruiting

The SPRAY study is an investigational double-blind, randomized, placebo-controlled, parallel group, dose range exploration study of Sativex® an investigational product, in managing persistent pain in patients with advanced cancer who experience inadequate analgesia during optimized chronic opioid therapy.